Blonder Tongue Laboratories, Inc.
BDRL
$0.0532
-$0.0068-11.33%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 109.71% | -249.75% | -170.91% | -178.74% | 61.58% |
| Total Depreciation and Amortization | -41.58% | -23.49% | -12.32% | -9.82% | 5.43% |
| Total Amortization of Deferred Charges | 6.90% | 0.00% | -44.44% | -42.59% | 93.33% |
| Total Other Non-Cash Items | 225.15% | 180.00% | 113.51% | -68.91% | -59.07% |
| Change in Net Operating Assets | -524.00% | 95.54% | -40.72% | 1,835.42% | -115.36% |
| Cash from Operations | 138.89% | 70.78% | -1,242.59% | -66.67% | 49.20% |
| Capital Expenditure | 31.58% | -350.00% | -87.50% | -- | 29.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 73.68% | 94.44% | 100.00% |
| Cash from Investing | 31.58% | -350.00% | 25.93% | 88.89% | 32.14% |
| Total Debt Issued | -72.94% | -- | -- | -- | -- |
| Total Debt Repaid | -598.59% | -187.68% | -46.15% | 73.99% | -73.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -71.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -150.71% | -93.57% | 306.86% | -12.80% | -48.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,033.33% | -165.75% | -12.85% | -1,161.54% | 150.00% |